We are live on
!
Find out more
RhumbLine Advisers Portfolio holdings
AUM
$117B
1-Year Est. Return
29.66%
This Fund
S&P 500
This Quarter
Est. Return
-13%
1 Year Est. Return
+29.66%
3 Year Est. Return
+101.47%
5 Year Est. Return
+137.35%
10 Year Est. Return
+530.92%
AUM
$46B
AUM Growth
-$5.82B
(-11%)
Cap. Flow
+$1.91B
Cap. Flow
% of AUM
4.16%
Top 10 Holdings %
Top 10 Hldgs %
16.37%
Holding
3,033
New
111
Increased
2,420
Reduced
427
Closed
53
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Linde
LIN
|
+$127M |
| 2 |
Cigna
CI
|
+$54M |
| 3 |
CVS Health
CVS
|
+$38.8M |
| 4 |
Marathon Petroleum
MPC
|
+$28.9M |
| 5 |
Diamondback Energy
FANG
|
+$19M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
AET
Aetna Inc
AET
|
+$124M |
| 2 |
ESRX
Express Scripts Holding Company
ESRX
|
+$100M |
| 3 |
PX
Praxair Inc
PX
|
+$80.2M |
| 4 |
COL
Rockwell Collins
COL
|
+$43.7M |
| 5 |
ANDV
Andeavor
ANDV
|
+$41M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 16.95% |
| 2 | Financials | 15.85% |
| 3 | Healthcare | 14.41% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Industrials | 10.09% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
TGH
2401
DELISTED
Textainer Group Holdings limited
TGH
| $396K | ﹤0.01% |
39,798
+11,858
| +42% | +$132K |
|
|
ECOM
2402
DELISTED
CHANNELADVISOR CORPORATION
ECOM
| $396K | ﹤0.01% |
34,855
+11,254
| +48% | +$126K |
|
2403
Artesian Resources
ARTNA
$355M
| $395K | ﹤0.01% |
11,333
+3,477
| +44% | +$125K |
|
2404
Global Industrial
GIC
$1.51B
| $395K | ﹤0.01% |
16,539
+5,274
| +47% | +$149K |
|
2405
Willdan Group
WLDN
$1.11B
| $393K | ﹤0.01% |
11,242
+4,240
| +61% | +$145K |
|
|
CNCE
2406
DELISTED
Concert Pharmaceuticals, Inc.
CNCE
| $392K | ﹤0.01% |
31,261
+9,313
| +42% | +$129K |
|
|
EMWP
2407
DELISTED
Eros Media World PLC
EMWP
| $392K | ﹤0.01% |
2,366
+834
| +54% | +$163K |
|
|
ONDK
2408
DELISTED
On Deck Capital, Inc.
ONDK
| $392K | ﹤0.01% |
66,427
+21,750
| +49% | +$155K |
|
2409
Limoneira
LMNR
$249M
| $391K | ﹤0.01% |
19,984
+6,711
| +51% | +$159K |
|
2410
Home Bancorp
HBCP
$567M
| $389K | ﹤0.01% |
10,998
+3,270
| +42% | +$127K |
|
|
AVLR
2411
DELISTED
Avalara, Inc.
AVLR
| $389K | ﹤0.01% |
12,495
+5,566
| +80% | +$180K |
|
2412
Atlanta Braves Holdings Series A
BATRA
$3.38B
| $388K | ﹤0.01% |
15,544
+4,285
| +38% | +$109K |
|
2413
Daily Journal
DJCO
$795M
| $388K | ﹤0.01% |
1,658
+490
| +42% | +$115K |
|
|
ZEUS
2414
DELISTED
Olympic Steel
ZEUS
| $387K | ﹤0.01% |
27,115
+4,508
| +20% | +$81.9K |
|
2415
Byline Bancorp
BY
$1.79B
| $386K | ﹤0.01% |
23,143
+7,137
| +45% | +$144K |
|
|
MOFG
2416
DELISTED
MidWestOne Financial Group
MOFG
| $386K | ﹤0.01% |
15,551
+4,758
| +44% | +$140K |
|
2417
Utah Medical Products
UTMD
$223M
| $386K | ﹤0.01% |
4,641
+1,576
| +51% | +$139K |
|
|
ARQL
2418
DELISTED
Arqule Inc
ARQL
| $386K | ﹤0.01% |
139,348
+52,064
| +60% | +$199K |
|
|
SIEN
2419
DELISTED
Sientra, Inc.
SIEN
| $385K | ﹤0.01% |
3,030
+1,018
| +51% | +$189K |
|
2420
ACNB Corp
ACNB
$661M
| $381K | ﹤0.01% |
9,714
+2,976
| +44% | +$112K |
|
2421
Citi Trends
CTRN
$600M
| $381K | ﹤0.01% |
18,693
+4,914
| +36% | +$116K |
|
2422
Lexicon Pharmaceuticals
LXRX
$1.05B
| $380K | ﹤0.01% |
57,193
+18,376
| +47% | +$149K |
|
2423
Accuray
ARAY
$33.8M
| $379K | ﹤0.01% |
111,093
+36,532
| +49% | +$148K |
|
2424
Ameresco
AMRC
$1.36B
| $378K | ﹤0.01% |
26,816
+8,288
| +45% | +$117K |
|
|
BBBY
2425
Bed Bath & Beyond
BBBY
$429M
| $378K | ﹤0.01% |
37,091
+12,513
| +51% | +$187K |
|
Similar funds
VAM
RhumbLine Advisers's Q4 2018 Portfolio in Review
As of Q4 2018, RhumbLine Advisers held 3,033 positions worth $46B, down 11% from $51.8B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
RhumbLine Advisers deployed $1.91B of net new capital in Q4 2018, opening 111 new positions and adding to 2,420 existing holdings. Its largest new stake was Linde: 805,738 shares worth $126M.
By sector, the portfolio is most concentrated in Technology at 17% of assets, down from 18% a quarter earlier, followed by Financials and Healthcare.
On the sell side, the largest reduction was Apple, an estimated $30.2M trimmed.
- RhumbLine Advisers's largest Q4 2018 buy was Linde: 805,738 shares worth $126M.
- RhumbLine Advisers added most to Cigna in Q4 2018, an estimated $54M increase.
- RhumbLine Advisers's biggest Q4 2018 reduction was Apple, cutting an estimated $30.2M.
- RhumbLine Advisers fully exited Aetna Inc in Q4 2018, selling an estimated $124M.
- RhumbLine Advisers's ten largest holdings make up 16% of its $46B portfolio in Q4 2018.
- RhumbLine Advisers opened 111 new positions and closed 53 in Q4 2018.
- RhumbLine Advisers's portfolio value fell 11% quarter-over-quarter to $46B.
Based on RhumbLine Advisers's 13F filing for Q4 2018, filed 31 Jan 2019.